Compliance Rate

Compliance Rate 51.23%
Compliant submissions 187
Incompliant submissions 178
Total trials 365

My Organizations' Clinical Trials

Showing 1450 of 2400 entries
View as:

A Study to Compare Two Different Anti-HIV Drug Regimens

Phase: N/A Priority: Normal
NCT ID: NCT00000924 Org: User:
Start: - End: 06/30/01 Due: 06/30/02

Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00000883 Org: User:
Start: 10/31/97 End: 04/30/07 Due: 04/30/08

A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 200 Mcg of gp120 (CHO) BIOCINE in MF59 Emulsion Versus the Emulsion Control: Three Injections at 0, 1, and 6 Months

Phase: N/A Priority: Normal
NCT ID: NCT00000749 Org: User:
Start: - End: - Due: -

Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S)

Phase: N/A Priority: Normal
NCT ID: NCT00000810 Org: User:
Start: - End: 01/31/96 Due: 01/31/97

Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine for the Neurological Manifestations of HIV-1

Phase: N/A Priority: Normal
NCT ID: NCT00000738 Org: User:
Start: - End: 06/30/94 Due: 06/30/95

Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00000689 Org: User:
Start: - End: 03/31/91 Due: 03/31/92

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of Low Dose MN rsgp120/HIV-1 (Genentech) in Combination With QS21 Adjuvant or Alum in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00000853 Org: User:
Start: - End: 01/31/99 Due: 01/31/00

A Placebo-Controlled, Phase I, Pilot Clinical Trial to Evaluate the Safety and Immunogenicity of ENV 2-3, a Yeast-Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59 in Individuals With HIV Infection (Placebo Patients Receive MF59 Emulsion Only)

Phase: N/A Priority: Normal
NCT ID: NCT00000958 Org: User:
Start: - End: 09/30/95 Due: 09/30/96

A Study of d4T in Patients With AIDS or AIDS-Related Complex Who Cannot Take AZT

Phase: N/A Priority: Normal
NCT ID: NCT00000686 Org: User:
Start: - End: - Due: -

A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin

Phase: N/A Priority: Normal
NCT ID: NCT00000778 Org: User:
Start: - End: - Due: -

A Prospective, Randomized, Open-Label, Comparative Trial of Dideoxyinosine (ddI) Versus Dideoxycytidine (ddC) in HIV-Infected Patients Who Are Intolerant of or Who Have Failed Zidovudine (AZT) Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00000969 Org: User:
Start: - End: 09/30/92 Due: 09/30/93

A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4 Immunoglobulin (rCd4-IgG) Administered by Intravenous Bolus in Patients With AIDS and AIDS Related Complex

Phase: N/A Priority: Normal
NCT ID: NCT00000675 Org: User:
Start: - End: - Due: -

A Randomized, Comparative Trial of Zidovudine (AZT) Versus 2',3'-Didehydro-3'-Deoxythymidine (Stavudine; d4T) in Children With HIV Infection

Phase: N/A Priority: Normal
NCT ID: NCT00000789 Org: User:
Start: - End: 07/31/98 Due: 07/31/99

Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00000726 Org: User:
Start: - End: 02/29/92 Due: 02/28/93

A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Vaccine Component P3C541b in HIV-1 Seronegative Human Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00000845 Org: User:
Start: - End: - Due: -

A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS

Phase: N/A Priority: Normal
NCT ID: NCT00000688 Org: User:
Start: - End: - Due: -

An Open Trial of Zidovudine (AZT) Treatment of the AIDS Dementia Complex in Patients With AIDS or Low CD4+ Lymphocyte Counts

Phase: N/A Priority: Normal
NCT ID: NCT00000709 Org: User:
Start: - End: 02/28/90 Due: 02/28/91

A Study of HIV in Newly Infected Individuals

Phase: N/A Priority: Normal
NCT ID: NCT00000930 Org: User:
Start: - End: 05/31/08 Due: 05/31/09

A Phase II/III Double-Blind Study of Amitriptyline and Mexiletine for Painful Neuropathy in HIV Infection

Phase: N/A Priority: Normal
NCT ID: NCT00000793 Org: User:
Start: - End: 10/31/97 Due: 10/31/98

Preventing Frequent Sinus Infections in HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00000752 Org: User:
Start: - End: 02/28/93 Due: 02/28/94

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seronegative Chronic Lyme Disease

Phase: N/A Priority: Normal
NCT ID: NCT00000938 Org: User:
Start: - End: 11/30/05 Due: 11/30/06

Continuous High-Dose Intravenous Dextran Sulfate in Human Immunodeficiency Virus-Infected Individuals

Phase: N/A Priority: Normal
NCT ID: NCT00000684 Org: User:
Start: - End: 04/30/91 Due: 04/30/92

A Randomized Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 Delivered by Alternate Mucosal Routes in HIV-1 Uninfected Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00000884 Org: User:
Start: - End: 10/31/00 Due: 10/31/01

A Study to Examine the Effects of Stopping Preventive Therapy for Disseminated Mycobacterium Avium Complex (DMAC) in HIV-Positive Patients

Phase: N/A Priority: Normal
NCT ID: NCT00000907 Org: User:
Start: - End: - Due: -

A Double-Blind, Placebo-Controlled Trial To Evaluate Intravenous Gamma Globulin in Children With Symptomatic HIV Infection Receiving Zidovudine

Phase: N/A Priority: Normal
NCT ID: NCT00000720 Org: User:
Start: - End: 04/30/93 Due: 04/30/94